These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25552129)

  • 1. Clinical response to a second uterine curettage in patients with low-risk gestational trophoblastic disease: a pilot study.
    Yarandi F; Jafari F; Shojaei H; Izadi-Mood N
    J Reprod Med; 2014; 59(11-12):566-70. PubMed ID: 25552129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.
    Hemida R; Vos EL; El-Deek B; Arafa M; Toson E; Burger CW; van Doorn HC
    Obstet Gynecol; 2019 May; 133(5):1024-1031. PubMed ID: 30969220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.
    Pezeshki M; Hancock BW; Silcocks P; Everard JE; Coleman J; Gillespie AM; Tidy J; Coleman RE
    Gynecol Oncol; 2004 Dec; 95(3):423-9. PubMed ID: 15581942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color Doppler sonography as an adjunct to repeat uterine evacuation for gestational trophoblastic disease: case report.
    Tsuyoshi H; Sugita G; Kurokawa T; Yoshida Y
    J Clin Ultrasound; 2013; 41 Suppl 1():54-8. PubMed ID: 23553374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
    J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
    Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
    J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.
    Vandewal A; Delbecque K; Van Rompuy AS; Noel JC; Marbaix E; Delvenne P; Nisolle M; Van Nieuwenhuysen E; Kridelka F; Vergote I; Goffin F; Han SN
    Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():95-99. PubMed ID: 33383413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.
    van Trommel NE; Massuger LF; Verheijen RH; Sweep FC; Thomas CM
    Gynecol Oncol; 2005 Oct; 99(1):6-13. PubMed ID: 16085294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study.
    Kan M; Yamamoto E; Niimi K; Tamakoshi K; Sekiya Y; Nishino K; Ino K; Kikkawa F
    J Reprod Med; 2016 Aug; 61(7-8):373-379. PubMed ID: 30408385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN.
    Hemida RA; Toson E; Van Doorn HC
    J Exp Ther Oncol; 2011; 9(3):217-20. PubMed ID: 22070053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Management of Gestational Trophoblastic Disease.
    Coopmans L; Larsson A; Joneborg U; Lok C; van Trommel N
    Gynecol Obstet Invest; 2024; 89(3):214-229. PubMed ID: 37788661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidiform moles.
    Sato A; Usui H; Shozu M
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):650-655. PubMed ID: 31542087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
    Chen YX; Shen YM; Qian JH; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of second curettage for treatment of low-risk non-metastatic gestational trophoblastic neoplasia.
    Batman S; Skeith A; Allen A; Munro E; Caughey A; Bruegl A
    Gynecol Oncol; 2020 Jun; 157(3):711-715. PubMed ID: 32276791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reservation of fertility for seventeen patients with placental site trophoblastic tumor].
    Zhao J; Xiang Y; Guo L; Wan X; Feng F; Ren T
    Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):265-9. PubMed ID: 24969333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.
    Goldstein DP; Garner EI; Feltmate CM; Berkowitz RS
    Gynecol Oncol; 2004 Dec; 95(3):421-2. PubMed ID: 15581941
    [No Abstract]   [Full Text] [Related]  

  • 19. Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.
    Osborne RJ; Filiaci VL; Schink JC; Mannel RS; Behbakht K; Hoffman JS; Spirtos NM; Chan JK; Tidy JA; Miller DS
    Obstet Gynecol; 2016 Sep; 128(3):535-542. PubMed ID: 27500329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
    Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.